Related Experiment Video
Updated: Jun 17, 2025
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Critical insights from recent outbreaks of Mycoplasma pneumoniae: decoding the challenges and effective interventions
Ravi Kant1, Naveen Kumar2, Yashpal Singh Malik3
1Medical Biotechnology Laboratory, Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, New Delhi, India.
Objectives:
Mycoplasma pneumoniae (M. pneumoniae) continues to pose a significant disease burden on global public health as a respiratory pathogen. The antimicrobial resistance among M. pneumoniae strains has complicated the outbreak control efforts, emphasizing the need for robust surveillance systems and effective antimicrobial stewardship programs.
Design:
This review comprehensively investigates studies stemming from previous outbreaks to emphasize the multifaceted nature of M. pneumoniae infections, encompassing epidemiological dynamics, diagnostic innovations, antibiotic resistance, and therapeutic challenges.
Results:
We explored the spectrum of clinical manifestations associated with M. pneumoniae infections, emphasizing the continuum of disease severity and the challenges in gradating it accurately. Artificial intelligence and machine learning have emerged as promising tools in M. pneumoniae diagnostics, offering enhanced accuracy and efficiency in identifying infections. However, their integration into clinical practice presents hurdles that need to be addressed. Further, we elucidate the pivotal role of pharmacological interventions in controlling and treating M. pneumoniae infections as the efficacy of existing therapies is jeopardized by evolving resistance mechanisms.
Conclusion:
Lessons learned from previous outbreaks underscore the importance of adaptive treatment strategies and proactive management approaches. Addressing these complexities demands a holistic approach integrating advanced technologies, genomic surveillance, and adaptive clinical strategies to effectively combat this pathogen.
Insights
Mycoplasma pneumoniae infections present a global health challenge due to rising antimicrobial resistance. Effective control requires advanced diagnostics, genomic surveillance, and adaptive treatment strategies informed by past outbreaks.
Area of Science:
- Respiratory Medicine
- Infectious Diseases
- Microbiology
Background:
- Mycoplasma pneumoniae is a significant global respiratory pathogen.
- Antimicrobial resistance in M. pneumoniae complicates outbreak control.
- There is a need for enhanced surveillance and antimicrobial stewardship.
Purpose of the Study:
- To review M. pneumoniae outbreaks, focusing on epidemiology, diagnostics, resistance, and therapeutics.
- To highlight challenges and innovations in managing M. pneumoniae infections.
- To inform adaptive strategies for combating this pathogen.
Main Methods:
- Comprehensive literature review of studies from previous M. pneumoniae outbreaks.
- Analysis of epidemiological dynamics, diagnostic advancements, and resistance patterns.
- Evaluation of current and emerging therapeutic interventions.
Main Results:
- M. pneumoniae infections exhibit a wide spectrum of clinical severity, posing diagnostic challenges.
- Artificial intelligence and machine learning show promise for improved diagnostics but face integration hurdles.
- Evolving antimicrobial resistance compromises existing therapies, necessitating adaptive pharmacological interventions.
Conclusions:
- Past outbreaks emphasize the need for adaptive treatment strategies and proactive management.
- A holistic approach integrating advanced technologies, genomic surveillance, and adaptive clinical strategies is crucial.
- Effective combatting of M. pneumoniae requires continuous innovation and strategic planning.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:18Steps in Outbreak Investigation